Education
About Us
Working with TipRanks
Follow Us
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
225 Mg Bnc210
Social Anxiety Disorder
Phase III
Completed
Efficacy of BNC210 in Acute, As-needed Treatment of Anxiety in Social Anxiety Disorder - 1
Jul 15, 2024
―
225 Mg Bnc210, 675 Mg Bnc210
Social Anxiety Disorder
Phase II
Completed
A Phase 2 Study of BNC210 for the Acute Treatment of Social Anxiety Disorder
Jan 03, 2022
―
Bnc210
Post-Traumatic Stress Disorder
Phase II
Completed
A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)
Jun 27, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Neuphoria Therapeutics (NEUP) have in its pipeline
NEUP is currently developing the following drugs: 225 Mg Bnc210, 225 Mg Bnc210, 675 Mg Bnc210, Bnc210. These drug candidates are in various stages of clinical development as the company works toward FDA approval.